Voloridge Investment Management
ABEO icon

Voloridge Investment Management’s Abeona Therapeutics ABEO Stock Holding History

Voloridge Investment Management’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-1,526
Closed -$86K – 1047
2019
Q3 		$86K Buy
+1,526
New +$114K ﹤0.01% 1021

Other funds holding ABEO

GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Voloridge Investment Management's ABEO Position: Q4 2019 in Review

Voloridge Investment Management sold out of Abeona Therapeutics (ABEO) in Q4 2019, closing a stake of 1,526 shares — an estimated $86K sold.

Voloridge Investment Management first reported a position in ABEO in Q3 2019 and held it in 1 quarter. The position peaked at $86K in Q3 2019. 87 funds tracked by Wall St. Rank hold ABEO as of Q4 2019.

  • Voloridge Investment Management reported no remaining Abeona Therapeutics position as of Q4 2019 after selling out during the quarter.
  • Voloridge Investment Management sold 1,526 Abeona Therapeutics shares in Q4 2019, an estimated $86K.
  • Voloridge Investment Management first reported a position in Abeona Therapeutics in Q3 2019 and held it in 1 quarter.
  • Voloridge Investment Management's Abeona Therapeutics position peaked at $86K in Q3 2019.
  • 87 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q4 2019.

Based on Voloridge Investment Management's 13F filing for Q4 2019, filed 14 Feb 2020.